Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SET and MYND Domain-Containing Protein 3 (SMYD3) Polymorphism as a Risk Factor for Susceptibility and Poor Prognosis in Ovarian Cancer.

Medical science monitor : international medical journal of experimental and clinical research - 26 Dec 2016

Liu Ting-Ting, Xu Hui, Gao Wei-Ping, Zhang Shu-Xiang, Zhou Xu-Hong, Tang Juan, Liu Qiong-Na

Abstract excerpt

BACKGROUND We investigated the relationship of the polymorphisms of SET and MYND domain-containing protein 3 (SMYD3) with risk and prognosis of ovarian cancer. MATERIAL AND METHODS The polymerase chain reaction (PCR) amplification method was applied to detect the polymorphisms of variable number of tandem repeats (VNTR) in the SMYD3 gene promoter region for 156 patients with ovarian cancer (case group) and 174...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Histone-Lysine N-Methyltransferase
Share to Kaplan-Meier Estimate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Logistic Models

Share to Minisatellite Repeats

Share to Multivariate Analysis

Share to Ovarian Neoplasms

Share to Proportional Hazards Models

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 28024138
DOI: 10.12659/msm.898095
PMCID: PMC5207010

Genes

SMYD3
SET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

SET and MYND Domain-Containing Protein 3 (SMYD3) Polymorphism as a Risk Factor for Susceptibility and Poor Prognosis in Ovarian Cancer.PMID 28024138Read ↗

The SMYD3 VNTR 3/3 polymorphism confers an increased risk and poor prognosis of hepatocellular carcinoma in a Chinese population.Semantic proximity Read ↗

Correlations of EZH2 and SMYD3 gene polymorphisms with breast cancer susceptibility and prognosis.Semantic proximity Read ↗

Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma.Semantic proximity Read ↗

Dynamin 3 Gene as a Tumor Suppressor and an Independent Predictive Factor of Poor Prognosis in Patients with Gastric CancerSemantic proximity Read ↗

Overexpression of SETD7 is Associated with Progression of Ovarian CancerSemantic proximity Read ↗

SMYD3 tandem repeats polymorphism is not associated with the occurrence and metastasis of hepatocellular carcinoma in a Chinese population.Semantic proximity Read ↗

Association analysis of ERBB2 amplicon genetic polymorphisms and STARD3 expression with risk of gastric cancer in the Chinese population.Semantic proximity Read ↗

Genetic variants and expression of the TIM-3 gene are associated with clinical prognosis in patients with epithelial ovarian cancer.Semantic proximity Read ↗

A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5' flanking region of SMYD3 is a risk factor for human cancers.Semantic proximity Read ↗

Increased expression of TET3 predicts unfavorable prognosis in patients with ovarian cancer-a bioinformatics integrative analysis.Semantic proximity Read ↗

Association of the variable number of tandem repeats polymorphism in the promoter region of the SMYD3 gene with risk of esophageal squamous cell carcinoma in relation to tobacco smoking.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.